CAS 1018946-38-7

Fórmula: C20H22O4

InChI: InChI=1S/C20H22O4/c1-21-10-4-5-14-6-8-17-16(11-14)13-19(24-17)15-7-9-18(22-2)20(12-15)23-3/h6-9,11-13H,4-5,10H2,1-3H3

Chave InChI: CUEPJIGXQLIOIK-UHFFFAOYSA-N

SMILES: COCCCC1=CC2=C(C=C1)OC(=C2)C3=CC(=C(C=C3)OC)OC

MDR-1339

CAS: 1018946-38-7

MDR-1339

Fórmula: C₂₀H₂₂O₄

Pureza: 99%

Peso molecular: 326.39

Ref: 54-BUP12723

DWK-1339

CAS: 1018946-38-7

DWK-1339 is a benzofuran derivative with pharmacokinetic properties that resemble those of the benzodiazepine class of drugs. It has been shown to have a good oral absorption and low systemic clearance, which may make it suitable for use in patients with impaired or reduced kidney function. DWK-1339's duration of action is between 8 and 12 hours in animals, and its elimination half-life is approximately 10 hours. The drug also has a high affinity for red blood cells, tissues, and muscle tissue.

Fórmula: C₂₀H₂₂O₄

Pureza: Min. 95%

Peso molecular: 326.39 g/mol

Ref: 3D-TQB94638

MDR-1339

CAS: 1018946-38-7

MDR-1339 is a blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.

Fórmula: C₂₀H₂₂O₄

Pureza: 99.12%

Cor e Forma: Solid

Peso molecular: 326.3863

Ref: TM-TQ0026

Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-

CAS: 1018946-38-7

Fórmula: C₂₀H₂₂O₄

Pureza: 98%

Cor e Forma: Liquid

Peso molecular: 326.3863

Ref: IN-DA0005U5